Top Markets
#1 Islamic Coin Islamic Coin +158.12%
#2 Glidr Glidr +58.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#4 Cryptopia Cryptopia +15.19%
#5 Victoria VR Victoria VR +13.77%
#6 Palladium Network Palladium Network +9.99%
#7 COTI COTI +6.95%
#8 龙虾 (Lobster) 龙虾 (Lobster) +6.45%
#9 DMT-NAT DMT-NAT +6.37%
#10 Movement Movement +6.02%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc.

TMBR
Classement en actions #42059
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions. The company's key product candidates include: TMB-001, a patented topical isotretinoin formulation, which has successfully completed Phase 2b clinical trials. It is designed to address moderate to severe forms of Congenital Ichthyosis (CI), a group of uncommon genetic disorders affecting skin keratinization. TMB-002, a proprietary topical rapamycin, currently undergoing Phase 2b clinical trials. This therapy targets facial angiofibroma associated with Tuberous Sclerosis Complex, a complex genetic disorder characterized by the growth of benign tumors in multiple organs. TMB-003, a unique Sitaxsentan formulation functioning as a selective endothelin-A receptor antagonist, which is in preclinical development for various sclerotic skin diseases. Additionally, through a licensing agreement with AFT Pharmaceuticals Limited, Timber Pharmaceuticals is advancing two topical minocycline therapies: BPX-01, now in Phase 3 development for treating inflammatory lesions of acne vulgaris. BPX-04, which is prepared for Phase 3 trials, targeting papulopustular rosacea. Founded in 2019, Timber Pharmaceuticals is headquartered in Basking Ridge, New Jersey.
Prix de l'action
$0.0101
Dernière synchronisation: 2023-12-26
Capitalisation boursière
$5.32K
Changement (1 jour)
741.67%
Changement (1 an)
0.00%
Pays
US
Échange Timber Pharmaceuticals, Inc. (TMBR)

Catégorie

Healthcare
Le prix TMBR avec la capitalisation boursière de B
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
TMBR
$0.0101
Capitalisation boursière de Timber Pharmaceuticals, Inc.(TMBR)
Capitalisation boursière: $5.32K
En August 2026, Timber Pharmaceuticals, Inc. a une capitalisation boursière de $5.32K. Cela fait de Timber Pharmaceuticals, Inc. la 42059th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Timber Pharmaceuticals, Inc. du 2014 au 2026
TMBR par rapport au top 5 des plus populaires stocks
Prix pour TMBR L’actif B La capitalisation boursière de B Résultats
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$10,227,038 $5.32K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +101,257,803,053.34%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$8,403,338 $5.32K
Apple Inc. Apple Inc.
AAPL
$4.423T +83,201,368,693.29%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$7,903,663 $5.32K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +78,254,084,322.11%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$6,959,394 $5.32K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +68,904,895,245.87%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$5,492,612 $5.32K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +54,382,301,214.11%